927871-76-9,MFCD12546447
Catalog No.:AA00GW6D

927871-76-9 | S107

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
95%
in stock  
$21.00   $15.00
- +
5mg
95%
in stock  
$59.00   $42.00
- +
10mg
95%
in stock  
$100.00   $70.00
- +
50mg
95%
in stock  
$157.00   $110.00
- +
100mg
95%
in stock  
$214.00   $150.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GW6D
Chemical Name:
S107
CAS Number:
927871-76-9
Molecular Formula:
C11H15NOS
Molecular Weight:
209.3079
MDL Number:
MFCD12546447
SMILES:
COc1ccc2c(c1)CN(C)CCS2
Properties
Computed Properties
 
Complexity:
188  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2  

Literature

Title: Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.

Journal: Circulation research 20120831

Title: Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging.

Journal: Cell metabolism 20110803

Title: Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective.

Journal: Pharmacology & therapeutics 20110801

Title: Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes.

Journal: Journal of mass spectrometry : JMS 20110201

Title: Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control.

Journal: Rapid communications in mass spectrometry : RCM 20090801

Title: Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503.

Journal: Rapid communications in mass spectrometry : RCM 20090401

Title: Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis.

Journal: Drug testing and analysis 20090101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:927871-76-9 Molecular Formula|927871-76-9 MDL|927871-76-9 SMILES|927871-76-9 S107
Catalog No.: AA00GW6D
927871-76-9,MFCD12546447
927871-76-9 | S107
Pack Size: 1mg
Purity: 95%
in stock
$21.00 $15.00
Pack Size: 5mg
Purity: 95%
in stock
$59.00 $42.00
Pack Size: 10mg
Purity: 95%
in stock
$100.00 $70.00
Pack Size: 50mg
Purity: 95%
in stock
$157.00 $110.00
Pack Size: 100mg
Purity: 95%
in stock
$214.00 $150.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GW6D
Chemical Name: S107
CAS Number: 927871-76-9
Molecular Formula: C11H15NOS
Molecular Weight: 209.3079
MDL Number: MFCD12546447
SMILES: COc1ccc2c(c1)CN(C)CCS2
Properties
Complexity: 188  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2  
Literature fold

Title: Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.

Journal: Circulation research20120831

Title: Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging.

Journal: Cell metabolism20110803

Title: Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective.

Journal: Pharmacology & therapeutics20110801

Title: Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes.

Journal: Journal of mass spectrometry : JMS20110201

Title: Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control.

Journal: Rapid communications in mass spectrometry : RCM20090801

Title: Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503.

Journal: Rapid communications in mass spectrometry : RCM20090401

Title: Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis.

Journal: Drug testing and analysis20090101

Building Blocks More >
861119-08-6
861119-08-6
A 844606
AA00GWR9 | MFCD22683835
914453-95-5
914453-95-5
Atosiban Acetate
AA00GXC6 | MFCD08692014
87233-62-3
87233-62-3
Emedastine difumarate
AA00GXTB | MFCD00923844
889939-41-7
889939-41-7
6-Bromo-3h-imidazo[4,5-b]pyridine-5-carboxylic acid
AA00GY78 | MFCD04971953
886510-29-8
886510-29-8
1-(DIFLUOROMETHYL)-2,4,5-TRIFLUOROBENZENE
AA00GZK8 | MFCD08276247
91652-00-5
91652-00-5
4-([6-(METHACRYLOYLOXY)HEXYL]OXY)BENZENECARBOXYLIC ACID
AA00H04J | MFCD01166369
898562-94-2
898562-94-2
Quinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-
AA00H0EO | MFCD09743765
886762-71-6
886762-71-6
2-Fluoro-6-iodonitrobenzene
AA00H0X6 | MFCD07368790
92041-43-5
92041-43-5
1-(4-Hydroxy-3-(morpholinomethyl)phenyl)ethanone hydrochloride
AA00H18Z | MFCD08445305
860457-99-4
860457-99-4
Ethyl 6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
AA00H1LD | MFCD11100212
Submit
© 2017 AA BLOCKS, INC. All rights reserved.